Pub. Date : 2020 Feb 5
PMID : 31767149
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Tyrosine kinase inhibitors (TKIs) that target BCR-ABL are the standard first-line therapy for patients with chronic-phase CML. | Tyrosine | ABL proto-oncogene 1, non-receptor tyrosine kinase | Homo sapiens |